Crosstalks Among Cancer Stem Cells and Histopathologic Features in Determining Prognosis in Canine Mammary Gland Carcinomas
By:
References
- 1. Nguyen F, Peña L, Ibisch C, Loussouarn D, Gama A, Rieder N, Belousov A, Campone M, Abadie J: Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors. Breast cancer research and treatment 2018, 167:635-648.10.1007/s10549-017-4548-2580749429086231
- 2. Rasotto R, Zappulli V, Castagnaro M, Goldschmidt MH: A retrospective study of those histopathologic parameters predictive of invasion of the lymphatic system by canine mammary carcinomas. Veterinary pathology 2012, 49:330-340.10.1177/030098581140925321670194
- 3. Gray M, Meehan J, Martínez-Pérez C, Kay C, Turnbull AK, Morrison LR, Pang LY, Argyle D: Naturally-occurring canine mammary tumors as a translational model for human breast cancer. Frontiers in oncology 2020,10.10.3389/fonc.2020.00617719876832411603
- 4. Marconato L, Facchinetti A, Zanardello C, Rossi E, Vidotto R, Capello K, Melchiotti E, Laganga P, Zamarchi R, Vascellari M: Detection and prognostic relevance of circulating and disseminated tumour cell in dogs with metastatic mammary carcinoma: a pilot study. Cancers 2019, 11:163.10.3390/cancers11020163640671630717110
- 5. Ayob AZ, Ramasamy TS: Cancer stem cells as key drivers of tumour progression. Journal of biomedical science 2018, 25:1-8.10.1186/s12929-018-0426-4583895429506506
- 6. Paul CD, Mistriotis P, Konstantopoulos K: Cancer cell motility: lessons from migration in confined spaces. Nature Reviews Cancer 2017, 17:131-140.10.1038/nrc.2016.123536449827909339
- 7. Ye F, Yu P, Li N, Yang A, Xie X, Tang H, Liu P: Prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in breast: A meta-analysis of PSM studies. The Breast 2020, 51:11-20.10.1016/j.breast.2020.01.041737557332172190
- 8. Lin H, Hong Y, Huang B, Liu X, Zheng J, Qiu S: Vimentin Overexpressions induced by cell hypoxia promote Vasculogenic mimicry by renal cell carcinoma cells. BioMed research international 2019, 2019.10.1155/2019/7259691667989531428643
- 9. Zhang JG, Zhou HM, Zhang X, Mu W, Hu JN, Liu GL, Li Q: Hypoxic induction of vasculogenic mimicry in hepatocellular carcinoma: role of HIF-1 α, RhoA/ROCK and Rac1/PAK signaling. BMC cancer 2020, 20:1-3.10.1186/s12885-019-6501-8695878931931758
- 10. Strouhalova K, Přechová M, Gandalovičová A, Brábek J, Gregor M, Rosel D: Vimentin intermediate filaments as potential target for cancer treatment. Cancers 2020, 12:184.10.3390/cancers12010184701723931940801
- 11. Te Boekhorst V, Friedl P: Plasticity of cancer cell invasion—Mechanisms and implications for therapy. Advances in cancer research 2016, 132:209-64.10.1016/bs.acr.2016.07.00527613134
- 12. Jahanban-Esfahlan R, Seidi K, Manjili MH, Jahanban-Esfahlan A, Javaheri T, Zare P: Tumor cell dormancy: threat or opportunity in the fight against cancer. Cancers 2019, 11:1207.10.3390/cancers11081207672180531430951
- 13. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.10.1016/j.cell.2008.03.027272803218485877
- 14. Strati A, Nikolaou M, Georgoulias V, Lianidou ES: Prognostic significance of TWIST1, CD24, CD44, and ALDH1 transcript quantification in EpCAM-positive circulating tumor cells from early stage breast cancer patients. Cells 2019, 8:652.10.3390/cells8070652667922231261917
- 15. Rybicka A, Król M; Identification and characterization of cancer stem cells in canine mammary tumors. Acta Veterinaria Scandinavica 2016, 58:1-7.10.1186/s13028-016-0268-6516871427993142
- 16. MaroufiNF, Amiri M, Dizaji BF, Vahedian V, Akbarzadeh M, Roshanravan N, Haiaty S, Nouri M, Rashidi MR: Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells. European Journal of Pharmacology 2020, 881:173282.10.1016/j.ejphar.2020.17328232580038
- 17. Meuten DJ. Tumors in domestic animals. 5th ed. Wiley Blackwell; 2016. pp. 723-765.10.1002/9781119181200
- 18. Clemente M, Perez-Alenza MD, Illera JC, Peña L: Histological, immunohistological, and ultrastructural description of vasculogenic mimicry in canine mammary cancer. Veterinary Pathology 2010, 47:265-274.10.1177/030098580935316720106772
- 19. Hujanen R, Almahmoudi R, Karinen S, Nwaru BI, Salo T, Salem A: Vasculogenic mimicry: a promising prognosticator in head and neck squamous cell carcinoma and esophageal cancer? a systematic review and meta-analysis. Cells 2020, 9:507.10.3390/cells9020507707276532102317
- 20. Mahooti S, Porter K, Alpaugh ML, Ye Y, Xiao Y, Jones S, Tellez JD, Barsky SH: Breast carcinomatous tumoral emboli can result from encircling lymphovasculogenesis rather than lymphovascular invasion. Oncotarget 2010, 1:131.10.18632/oncotarget.117
- 21. Chen J, Chen S, Zhuo L, Zhu Y, Zheng H: Regulation of cancer stem cell properties, angiogenesis, and vasculogenic mimicry by miR-450a-5p/SOX2 axis in colorectal cancer. Cell death & disease 2020, 11:1-3.10.1038/s41419-020-2361-z706032032144236
- 22. Prado MC, Macedo SD, Guiraldelli GG, de Faria Lainetti P, Leis-Filho AF, Kobayashi PE, Laufer-Amorim R, Fonseca-Alves CE: Investigation of the prognostic significance of vasculogenic mimicry and its inhibition by sorafenib in canine mammary gland tumors. Frontiers in oncology 2019, 9:1445.10.3389/fonc.2019.01445693092931921690
- 23. Xu J, Zhang Y, Wang Y, Tao X, Cheng L, Wu S, Tao Y: Correlation of KAI1, CD133 and vasculogenic mimicry with the prediction of metastasis and prognosis in hepatocellular carcinoma. International journal of clinical and experimental pathology 2018, 11:3638.
- 24. Andonegui-Elguera MA, Alfaro-Mora Y, Cáceres-Gutiérrez R, Caro-Sánchez CH, Herrera LA, Díaz-Chávez J: An Overview of Vasculogenic Mimicry in Breast Cancer. Frontiers in oncology 2020, 10.10.3389/fonc.2020.00220705688332175277
- 25. Lee SY, Jeong EK, Ju MK, Jeon HM, Kim MY, Kim CH, Park HG, Han SI, Kang HS: Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation. Molecular cancer 2017, 16:1-25.10.1186/s12943-016-0577-4528272428137309
- 26. Zhang X, Xing C, Guan W, Chen L, Guo K, Yu A, Xie K: Clinicopathological and prognostic significance of nestin expression in patients with breast cancer: a systematic review and meta-analysis. Cancer cell international 2020, 20:1-7.10.1186/s12935-020-01252-5722726432467665
- 27. Cao Z, Bao M, Miele L, Sarkar FH, Wang Z, Zhou Q: Tumour vasculogenic mimicry is associated with poor prognosis of human cancer patients: a systemic review and meta-analysis. European journal of cancer 2013, 49:3914-3923.10.1016/j.ejca.2013.07.14823992642
- 28. Wu Q, Wang J, Liu Y, Gong X: Epithelial cell adhesion molecule and epithelial-mesenchymal transition are associated with vasculogenic mimicry, poor prognosis, and metastasis of triple negative breast cancer. International journal of clinical and experimental pathology 2019, 12:1678.
- 29. Li S, Li Q: Cancer stem cells and tumor metastasis. International journal of oncology 2014, 44:1806-12.10.3892/ijo.2014.2362406353624691919
- 30. Ahmadi SA, Moinfar M, Moghaddam KG, Bahadori M: Practical application of angiogenesis and vasculogenic mimicry in prostatic adenocarcinoma. Archives of Iranian medicine 2010, 13:498-503.
- 31. Zhao XL, Du J, Zhang SW, Liu YX, Wang X, Sun BC: A study on vasculogenic mimicry in hepatocellular carcinoma. Zhonghua gan zang bing za zhi= Zhonghua ganzangbing zazhi= Chinese journal of hepatology 2006, 14:41-44.
- 32. Aleskandarany MA, Sonbul SN, Mukherjee A, Rakha EA: Molecular mechanisms underlying lymphovascular invasion in invasive breast cancer. Pathobiology 2015, 82:113-23.10.1159/00043358326330352
- 33. Lavenus SB, Tudor SM, Ullo MF, Vosatka KW, Logue JS: A flexible network of vimentin intermediate filaments promotes migration of amoeboid cancer cells through confined environments. Journal of Biological Chemistry 2020, 295:6700-6709.10.1074/jbc.RA119.011537721262232234762
- 34. Daubriac J, Han S, Grahovac J, Smith E, Hosein A, Buchanan M, Basik M, Boucher Y: The crosstalk between breast carcinoma-associated fibroblasts and cancer cells promotes RhoA-dependent invasion via IGF-1 and PAI-1. Oncotarget 2018, 9:10375.10.18632/oncotarget.23735582821329535813
- 35. Vorotnikov AV, Tyurin-Kuzmin PA: Chemotactic signaling in mesenchymal cells compared to amoeboid cells. Genes & diseases 2014, 1:162-73.10.1016/j.gendis.2014.09.006615006830258862
- 36. Yang YL, Liu BB, Zhang X, Fu L: Invasive micropapillary carcinoma of the breast: an update. Archives of pathology & laboratory medicine 2016, 140:799-805.10.5858/arpa.2016-0040-RA27472238
- 37. Lee JH, Kim JH, Choi JW, Kim YS: The presence of a micropapillary component predicts aggressive behaviour in early and advanced gastric adenocarcinomas. Pathology 2010, 42:560-563.10.3109/00313025.2010.50879020854075
- 38. Brown JM, Wasson MC, Marcato P: The missing Lnc: the potential of targeting triple-negative breast cancer and cancer stem cells by inhibiting long non-coding RNAs. Cells 2020, 9:763.10.3390/cells9030763714066232244924
- 39. Abadie J, Chocteau F, Loussouarn D, Nguyen F: Proposal for a Histological Staging System of Mammary Carcinomas in Dogs and Cats. Part 1: Canine Mammary Carcinomas. Frontiers in Veterinary Science 2019, 6:388.10.3389/fvets.2019.00388685402131788485
- 40. Liao GS, Hsu HM, Chu CH, Hong ZJ, Fu CY, Chou YC, Golshan M, Dai MS, Chen TW, De-Chian C, Tsai WC: Prognostic role of lymphovascular invasion and lymph node status among breast cancer subtypes. Journal of Medical Sciences 2018, 38:54.10.4103/jmedsci.jmedsci_105_17
- 41. Shi Y, Su WJ, Dai GZ: Development of a risk-stratification scoring system for predicting lymphovascular invasion in breast cancer. BMC cancer 2020, 20:94.10.1186/s12885-020-6578-0699885132013960
- 42. Ragage F, Debled M, MacGrogan G, Brouste V, Desrousseaux M, Soubeyran I, Tunon de Lara C, Mauriac L, de Mascarel I: Is it useful to detect lymphovascular invasion in lymph node-positive patients with primary operable breast cancer?. Cancer 2010, 116:3093-3101.10.1002/cncr.2513720564641
- 43. El Abbass KA, Abdellateif MS, Gawish AM, Zekri AR, Malash I, Bahnassy AA: The role of breast cancer stem cells and some related molecular biomarkers in metastatic and nonmetastatic breast cancer. Clinical breast cancer 2020, 20:e373-84.10.1016/j.clbc.2019.11.00832299754
- 44. Liu Y, Yang M, Luo J, Zhou H: Radiotherapy targeting cancer stem cells “awakens” them to induce tumour relapse and metastasis in oral cancer. International journal of oral science 2020, 12:1-12.10.1038/s41368-020-00087-0731153132576817
- 45. Szczubiał M, Łopuszynski W: Prognostic value of regional lymph node status in canine mammary carcinomas. Veterinary and comparative oncology 2011, 9: 296-303.10.1111/j.1476-5829.2011.00268.x22077411
- 46. Wei W, Hu H, Tan H, Chow LW, Yip AY, Loo WT: Relationship of CD44+ CD24-/low breast cancer stem cells and axillary lymph node metastasis. In Journal of translational medicine 2012, 10:1-6.10.1186/1479-5876-10-S1-S6344585823046710
- 47. Jones BC, Kelley LC, Loskutov YV, Marinak KM, Kozyreva VK, Smolkin MB, Pugacheva EN: Dual targeting of mesenchymal and amoeboid motility hinders metastatic behavior. Molecular Cancer Research 2017, 15:670-682.10.1158/1541-7786.MCR-16-0411545770528235899
- 48. Kariri YA, Aleskandarany MA, Joseph C, Kurozumi S, Mohammed OJ, Toss MS, Green AR, Rakha EA: Molecular Complexity of Lymphovascular Invasion: The Role of Cell Migration in Breast Cancer as a Prototype. Pathobiology 2020, 87:218-231.10.1159/00050833732645698
- 49. Cao R, Yuan L, Ma B, Wang G, Qiu W, Tian Y: An EMT-related gene signature for the prognosis of human bladder cancer. Journal of cellular and molecular medicine 2020, 24:605-617.10.1111/jcmm.14767693337231657881
- 50. Parvani JG, Schiemann WP: Sox4, EMT programs, and the metastatic progression of breast cancers: mastering the masters of EMT. Breast Cancer Research 2013, 15:1-3.10.1186/bcr3466397907623981787
- 51. Garg M: Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis. Expert Reviews in Molecular Medicine 2017, 19:1-13.10.1017/erm.2017.628322181
- 52. Luo A, Xu Y, Li S, Bao J, Lü J, Ding N, Zhao Q, Fu Y, Liu F, Cho WC, Wei X: Cancer stem cell property and gene signature in bone-metastatic Breast Cancer cells. International journal of biological sciences 2020, 16:2580-2594.10.7150/ijbs.45693741542232792858
- 53. Velasco-Velázquez MA, Popov VM, Lisanti MP, Pestell RG: The role of breast cancer stem cells in metastasis and therapeutic implications. The American journal of pathology 2011, 179:2-11.10.1016/j.ajpath.2011.03.005312386421640330
Language: English
Page range: 303 - 317
Accepted on: Aug 23, 2021
Published on: Sep 27, 2021
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2021 Havva Marzban, Gelareh Chamani, Fariba Khaki, Parnian Amini, Nastaran Pedram, Zeinab Asghari, Mohammadreza Boroomand, Samira Moradi, Artimes Yahyaei, Mersedeh Sadat Hossein Boroujerdi, Kamyab Valinezhad, published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 License.